Literature DB >> 8993473

In vitro identification of VIP receptors in human tumors: potential clinical implications.

J C Reubi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8993473     DOI: 10.1111/j.1749-6632.1996.tb17553.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometry.

Authors:  Rebecca J Hermann; Travis Van der Steen; Emilie E Vomhof-Dekrey; Sejaa Al-Badrani; Steve B Wanjara; Jarrett J Failing; Jodie S Haring; Glenn P Dorsam
Journal:  J Immunol Methods       Date:  2011-11-04       Impact factor: 2.303

2.  VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancer.

Authors:  Hayat Onyüksel; Prem S Mohanty; Israel Rubinstein
Journal:  Int J Pharm       Date:  2008-08-27       Impact factor: 5.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.